A detailed history of Zions Bancorporation, N.A. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 8,527 shares of CRL stock, worth $1.67 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
8,527
Previous 7,252 17.58%
Holding current value
$1.67 Million
Previous $1.5 Million 12.08%
% of portfolio
0.12%
Previous 0.12%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$187.96 - $245.29 $239,649 - $312,744
1,275 Added 17.58%
8,527 $1.68 Million
Q2 2024

Aug 08, 2024

SELL
$206.39 - $268.73 $48,295 - $62,882
-234 Reduced 3.13%
7,252 $1.5 Million
Q1 2024

May 14, 2024

BUY
$203.52 - $273.43 $61,666 - $82,849
303 Added 4.22%
7,486 $2.03 Million
Q4 2023

Feb 12, 2024

BUY
$164.52 - $238.84 $75,021 - $108,911
456 Added 6.78%
7,183 $1.7 Million
Q3 2023

Nov 07, 2023

BUY
$194.44 - $217.61 $286,410 - $320,539
1,473 Added 28.04%
6,727 $1.32 Million
Q2 2023

Jul 28, 2023

BUY
$183.71 - $210.25 $54,010 - $61,813
294 Added 5.93%
5,254 $1.1 Million
Q1 2023

May 10, 2023

BUY
$191.89 - $259.92 $110,144 - $149,194
574 Added 13.09%
4,960 $1 Million
Q4 2022

Feb 10, 2023

BUY
$197.11 - $250.07 $364,062 - $461,879
1,847 Added 72.75%
4,386 $955,000
Q3 2022

Nov 08, 2022

BUY
$182.44 - $250.54 $462,667 - $635,369
2,536 Added 84533.33%
2,539 $500,000
Q2 2022

Aug 05, 2022

SELL
$204.13 - $302.4 $612 - $907
-3 Reduced 50.0%
3 $1,000
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $22,484 - $31,865
-88 Reduced 93.62%
6 $2,000
Q4 2021

Feb 11, 2022

BUY
$351.38 - $448.68 $1,405 - $1,794
4 Added 4.44%
94 $35,000
Q3 2021

Nov 10, 2021

SELL
$372.64 - $458.3 $888,746 - $1.09 Million
-2,385 Reduced 96.36%
90 $37,000
Q2 2021

Aug 11, 2021

BUY
$294.17 - $371.65 $86,780 - $109,636
295 Added 13.53%
2,475 $916,000
Q1 2021

May 13, 2021

SELL
$249.67 - $299.48 $3,495 - $4,192
-14 Reduced 0.64%
2,180 $632,000
Q4 2020

Feb 12, 2021

BUY
$222.0 - $252.62 $14,874 - $16,925
67 Added 3.15%
2,194 $548,000
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $15,273 - $19,701
-87 Reduced 3.93%
2,127 $482,000
Q2 2020

Aug 13, 2020

BUY
$118.84 - $189.72 $22,460 - $35,857
189 Added 9.33%
2,214 $386,000
Q1 2020

May 15, 2020

BUY
$98.9 - $178.34 $17,505 - $31,566
177 Added 9.58%
2,025 $256,000
Q4 2019

Feb 14, 2020

SELL
$126.05 - $152.76 $59,117 - $71,644
-469 Reduced 20.24%
1,848 $282,000
Q3 2019

Nov 13, 2019

SELL
$125.07 - $143.67 $13,007 - $14,941
-104 Reduced 4.3%
2,317 $307,000
Q2 2019

Jul 09, 2019

BUY
$123.4 - $148.55 $15,301 - $18,420
124 Added 5.4%
2,421 $344,000
Q1 2019

May 10, 2019

BUY
$104.82 - $146.73 $240,771 - $337,038
2,297 New
2,297 $334,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Zions Bancorporation, N.A. Portfolio

Follow Zions Bancorporation, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.